The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 13, 2017
Filed:
Nov. 30, 2012
Applicant:
3m Innovative Properties Company, St. Paul, MN (US);
Inventors:
Assignee:
3M Innovative Properties Company, St. Paul, MN (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61M 5/24 (2006.01); A61K 38/29 (2006.01); A61K 9/00 (2006.01); A61M 37/00 (2006.01); A61K 31/4172 (2006.01); A61K 47/18 (2017.01); A61K 38/23 (2006.01); A61K 38/28 (2006.01); A61K 38/47 (2006.01); A61K 31/198 (2006.01); A61L 31/10 (2006.01); A61L 31/16 (2006.01); A61K 38/22 (2006.01); A61K 47/22 (2006.01);
U.S. Cl.
CPC ...
A61K 38/29 (2013.01); A61K 9/0021 (2013.01); A61K 9/0087 (2013.01); A61K 31/198 (2013.01); A61K 31/4172 (2013.01); A61K 38/225 (2013.01); A61K 38/23 (2013.01); A61K 38/28 (2013.01); A61K 38/47 (2013.01); A61K 47/183 (2013.01); A61K 47/22 (2013.01); A61L 31/10 (2013.01); A61L 31/16 (2013.01); A61M 37/0015 (2013.01); A61L 2300/214 (2013.01); A61L 2300/252 (2013.01); A61M 2037/0023 (2013.01); A61M 2037/0046 (2013.01); A61M 2037/0053 (2013.01);
Abstract
A medical device including an array of microneedles and a coating disposed on or within the microneedles and a method of making such a device are disclosed. The coating includes a peptide therapeutic agent and an amino acid. A method of stabilizing a peptide therapeutic agent with an amino acid on an array of microneedles is also disclosed. In some cases, the peptide therapeutic agent and the amino acid either both have a net positive charge or both have a net negative charge. In some cases, the peptide therapeutic agent is histidine.